Why is astrazeneca buying shares back

On July 29, AstraZeneca released its earnings for the first half of As well as the company did this past period, it could do even better in future quarters and years. AstraZeneca still plans to apply for authorization of its vaccine in the U. Alexion has many orphan drugs in its portfolio that treat rare conditions. Ultomiris treats patients with paroxysmal nocturnal hemoglobinuria, a rare blood disease that can be life-threatening.

Over the long term, there's even more potential for AstraZeneca, which had a total of projects in its pipeline -- including 13 that are in late stages -- even before the acquisition.

Alexion's pipeline has contributed another 30 therapies. While it may not be a dirt cheap buy, AstraZeneca doesn't look expensive, either.

And it has the potential to be a bargain, depending on how well its pipeline pans out. Its sales and profits could grow significantly over the years, especially now that it's expanded its portfolio with the acquisition of Alexion. I wouldn't suggest this as a healthcare stock to buy if you're simply looking for a company that will do well due to its COVID vaccine. With so many projects in its pipeline, there's likely to be some strong growth in its future.

Another reason to consider the stock for the long haul would be for its dividend yield, currently 2. Although AstraZeneca hasn't been a great investment over the past 12 months, there are plenty of reasons to remain bullish on the stock in the years ahead.

Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Honouring Exemplary Boards. Deep Dive Into Cryptocurrency. ET Markets Conclave — Cryptocurrency.

Reshape Tomorrow Tomorrow is different. Let's reshape it today. Corning Gorilla Glass TougherTogether. ET India Inc. ET Engage. ET Secure IT. Cryptocurrency By. Stocks Dons of Dalal Street. Live Blog. Stock Reports Plus. Candlestick Screener. Stock Screener. Market Classroom. Stock Watch. Market Calendar. Stock Price Quotes.

Markets Data. Market Moguls. Expert Views. Technicals Technical Chart. Commodities Views News. Forex Forex News. Currency Converter. AstraZeneca Pharma Indi Add to Watchlist. Insights View All. Please add to watchlist to track closely. Contingent Liabilities Coverage Company has sufficient cash reserves to pay off its contingent liabilities.

Do you find these insights useful? Key Metrics PE Ratio PE Ratio This is a ratio arrived at by dividing the current market price of a stock by its latest annual or annualized earnings per share. MCap MCap MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.

Div Yield Dividend Yield Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock.

Face Value Face Value Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. Beta Beta 1 Month PE Ratio PE Ratio This is a ratio arrived at by dividing the current market price of a stock by its latest annual or annualized earnings per share. Dividend Yield Dividend Yield Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock.

Returns 1 Day 0. Stock Score. Recommendations No Recommendations details available for this stock. Financials Consolidated Standalone. Insights Topline Contraction Sales de-grew by 2. Close drawer menu Financial Times International Edition. Search the FT Search. World Show more World. US Show more US. Companies Show more Companies. Markets Show more Markets. Opinion Show more Opinion. Personal Finance Show more Personal Finance.